Vaccine Development

CSC's DVC Achieves Significant Milestones in Department of Defense Contract

Published in Vaccine Weekly, April 11th, 2007

Computer Sciences Corporation (NYSE:CSC) announced that DynPort Vaccine Company LLC (DVC), a CSC company, has made significant progress on several biodefense vaccine development programs it manages for the U.S. Department of Defense Joint Vaccine Acquisition Program (JVAP).

DVC has served as prime systems contractor for the JVAP since 1997, and has since made considerable progress in the advanced development of several biodefense vaccines. Since 2005, DVC has initiated Phase 1 clinical trials for three JVAP biodefense vaccine development programs, all of which were developed by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). These are a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2007-04-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry